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ABSTRACT
STEVEN BUSAN: Frameworks for large-scale RNA structure profiling in transcriptomes
and disease.
(Under the direction of Kevin M. Weeks)
In addition to their role as intermediaries on the route to protein synthesis, RNA
molecules have long been known to base-pair into complex structures that serve specific
functions. Some structured RNAs play pathogenic roles, especially in viral illnesses
and repeat-expansion disorders, and disease-associated RNA structures are potential
therapeutic targets. SHAPE is a well-established chemical probing strategy to interrogate
RNA flexibility and obtain high-quality structure models. The recent development of an
unbiased experimental approach that allows SHAPE to characterize populations of diverse
RNAs using massively parallel sequencing presented a challenging data analysis problem.
In this work, I apply SHAPE to study the relevance of huntingtin mRNA structure to
Huntington’s disease and discover that a classical CAG hairpin is likely absent or short in
healthy-length transcripts. The formation of this hairpin correlates with increasing repeat
length, which is a predictor of disease severity. I develop a fully-automated data analysis
pipeline allowing for the extension of the SHAPE strategy to larger scales using mutational
profiling (MaP), an approach that was applied to identify highly-structured elements within
an HIV-1 genome. I further pursue a pilot analysis of a bacterial transcriptome MaP dataset
obtained in a single experiment, demonstrate the nucleotide accuracy of MaP within this
large sample, and apply alignment clustering to identify conserved motifs at the genomic
scale. Together, these three projects highlight the power of SHAPE to identify specific
RNA structures related to human disease and the value of robust experimental design and
careful analysis in large-scale sequencing studies of RNA structure.
iii
“An intellectual is a man who says a simple thing in a difficult way;
an artist is a man who says a difficult thing in a simple way.”
- Bukowski
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1 INTRODUCTION
1.1 RNA structure
The description of the iconic DNA double helix in 19531 propelled speculation as
to the possibility of RNA helices, first experimentally confirmed using X-ray diffraction
in 19562. By the early ’60s, it was apparent that ribosomal RNA (rRNA), transfer
RNA (tRNA), and certain plant virus RNAs contained a high proportion of anti-parallel
helical elements3, but the specific nature of these elements was unknown. In 1964,
measurements of the reaction rates of formaldehyde with tRNA supported the idea that
native ribonucleotides exist in one of three states: strongly hydrogen bonded (that is, base
paired), partially constrained, or flexible4. The first full nucleotide sequence of a tRNA
(primary structure) was published the following year, along with a set of proposed base
pairs (secondary structure)5. An atomic-level description of the three-dimensional structure
of a tRNA (tertiary structure) would not be obtained until 19746 (see Figure 1.1).
Over the last four decades, an array of specialized functional RNA structures have
been described. These include small regulatory RNAs, catalytic RNAs, such as ribosomal
RNAs and self-cleaving ribozymes, and riboswitches, RNAs that modulate gene expression
by binding specific metabolites8. In all of these cases, RNA molecules do not simply carry
sequence information, but instead fold into specific structural states that allow the chemical
interactions necessary for their roles in the cell.
1.1.1 RNA structures as pathogenic agents and therapeutic targets
RNA structures play pathogenic roles in human diseases. Of particular relevance
to Chapter 2 of this work are the subset of triplet repeat expansion disorders in which
long repeat-expanded RNA gains a toxic function. For example, myotonic dystrophy
type 1 is caused by the expansion of a CUG repeat region in a portion of the myotonin
1
AB C
3′5′
5′
3′
Figure 1.1: Hierarchy of RNA structure. (A) Primary, (B) secondary, and (C) tertiary
structures of the yeast phenylalanine tRNA. Post-transcriptional modifications are ignored
for simplicity. Three-dimensional model from Protein Data Bank entry 4TNA7.
protein kinase gene that does not code for protein. Myotonic dystrophy type 1 appears
to result from the nuclear sequestration of RNA-binding proteins such as muscleblind-like
(MBNL1) by CUG hairpin helices and the improper RNA splicing that results9. Repeat-
expanded RNAs are proposed to be the primary pathogenic agents in fragile X-associated
tremor/ataxia syndrome and spinocerebellar ataxia type 8, and are suspected to cause
pathogenic effects in many more triplet-repeat expansion diseases, including Huntington’s
disease and Huntington’s disease-like syndrome 210.
Disease-associated RNA structures are potential targets for therapeutic intervention.
Small molecule drugs are able to selectively bind certain structured RNAs. For example,
several major classes of antibiotics specifically bind the bacterial ribosomal RNA11. In
repeat-expansion disease research, a recent report identified a small molecule that binds
CUG:CUG helices and inhibits the sequestration of MBNL1 protein in a cell culture
2
model of myotonic dystrophy12. Therapeutic development has not been limited to small
molecules, however, as many groups have pursued the use of antisense oligonucleotides13,
modular peptoid scaffolds14, zinc finger proteins15, and antibodies16 to bind RNA targets.
Disease-associated RNA structure targets are not limited to repeat expansion disorders
and bacterial infection. Illnesses caused by viral infections provide another broad class of
valuable RNA structure targets, since many viruses that infect humans use structured RNA
at critical stages in their replication cycles. For example, human immunodeficiency virus
(HIV) relies on a highly structured RNA element for the nuclear export of its messenger
RNAs (mRNAs) and their eventual packaging into virus particles17. Hepatitis C virus
(HCV) RNA contains a structure that serves as a ribosomal entry site, allowing for the
translation of viral proteins18. Dengue virus contains two “dumbbell” structures important
for RNA replication and translation19. The identification and characterization of functional
RNA structures are necessary steps preceding nearly all efforts to therapeutically target
RNA structure. These remain challenging problems, especially within the larger context of
the transcriptome (all the RNAs produced in a cell).
1.1.2 RNA structures within transcriptomes
The development of massively parallel sequencing technologies (to be discussed
briefly in Section 1.3.1) gave rise to the genomic era, creating a present in which
the identities of billions of nucleotides of DNA and RNA are determined per day
globally20. This vast landscape heightens the need for strategies to quickly identify specific
structured RNAs in the transcriptome, since only a subset of all RNAs have evolved
functional structures. A small number of highly-expressed non-coding transcripts have
been fully structurally characterized, including the ribosome (the structural core of the
protein translation machinery)21, transfer-messenger RNA (responsible for releasing stalled
ribosomes)22, RNase P (a catalytic RNA cleaving the ends of tRNAs)23, and 6S RNA
(a transcription regulator)24. In addition, small stable hairpin structures that terminate
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transcription have been identified in numerous locations in bacterial transcriptomes, largely
by computational sequence searches25. To find functional RNA structures among the full
complement of cellular RNAs, strategies are needed to rapidly locate RNAs with low free
energies of folding. A first step along this route is to accurately map RNA flexibility at
the transcriptome scale, something that many research groups are working toward (to be
discussed in Section 1.3.2).
1.2 SHAPE
1.2.1 Rationale
Mapping RNA flexibility is an important tool in developing RNA structure models,
and has been used since the early days of RNA structure analysis. For a transcript longer
than a few dozen nucleotides, predicting which nucleotides will form base pairs is difficult
by visual inspection of the sequence alone. Knowing which nucleotides are in highly
constrained versus flexible structural states greatly reduces the magnitude of this problem.
Therefore, chemistries and enzymes that react with RNA in a structure-selective manner
have been exploited to improve structure models by providing this additional empirical
information.
1.2.2 Chemical and enzymatic probing methods
The earliest plausible secondary structure models for RNAs longer than 100
nucleotides were developed by visually attempting to maximize the number of base pairs
while leaving single-stranded those nucleotides that showed sensitivity to cleavage by
various agents. For example, in 1978, a long rod-like structure model was proposed for
a 359-nucleotide potato spindle tuber virus RNA, using bisulphite modification (which
preferentially reacts with single-stranded cytosine residues) and a number of structure-
specific ribonuclease (RNase) digests26. In this and other early studies, both nucleotide
sequences and the locations of RNA cleavage or modification were detected by labor-
intensive two-dimensional gel eletrophoretic techniques.
4
More efficient methods to locate sites of cleavage or modification were later
developed, the most useful of which has been reverse transcription primer extension. This
method relies on the annealing of a labeled DNA primer to the 3′ end of an RNA, the
extension of this primer by a reverse transcriptase enzyme, and the resulting production
of DNA fragments whose 3′ ends correspond to sites of RNA cleavage or modification27.
These DNA fragments are resolved by gel or capillary electrophoresis to determine the
locations and magnitudes of cleavage or modification28.
Reverse transcription primer extension can be used to quantify the levels of RNA
reactivity with a wide variety of chemical probes and nucleases. Common chemical
examples are DMS (which reacts with single-stranded adenosines and cytosines), CMCT
(which modifies single-stranded uridines and guanosines), kethoxal (which modifies single-
stranded guanosines), and in-line probing (the spontaneous cleavage of flexible nucleotides
in ionic solution)29. Primer extension can also report on chemical probes that measure
nucleotide properties other than flexibility. For example, nucleotides cleaved by hydroxyl
radical attack tend to be located on the surface of a given molecule and exposed to
the surrounding solvent30. Popular enzymatic nucleases include RNase I (which cleaves
upstream of single-stranded nucleotides of all types) and RNase V1 (which cleaves base-
paired helical regions), often used in tandem31. However, the comparatively large size
of RNase proteins precludes true single-nucleotide measurement32. As useful as all these
reagents have been, accurately modeling RNA structures using incomplete or nucleotide-
biased data is challenging33.
1.2.3 Structure modeling
Efforts to automate RNA structure prediction have gradually improved over time. The
first software to achieve limited success estimated the free energy of each possible structure
by summing the modeled free energy contributions of each base pair, loop, and bulge34.
Data from more extensive thermodynamic experiments were incorporated in a later version
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of the software, estimating the energetic contributions of base pairs two at a time instead of
alone (referred to as a “nearest-neighbor” energy model)35. The development of a dynamic
programming algorithm for efficiently computing a minimum free energy RNA structure in
1980 brought RNA structure modeling within practical reach36. Thermodynamic models
have continued to be refined37–39, but de novo structure modeling accuracies remain modest
for RNAs over a few dozen nucleotides in length40.
1.2.4 Development of SHAPE
The limitations of prior chemical and enzymatic RNA structure probing methods
spurred the development of selective 2′-hydroxyl acylation analyzed by primer extension
(SHAPE), first reported in 200541. SHAPE reagents are electrophiles that selectively
react with the 2′-hydroxyl group on the RNA backbone, a group common to all four
ribonucleotides (see Figure 1.2). SHAPE therefore reports on the local flexibility (and by
proxy, base pairing status) of nearly all the nucleotides in a given RNA molecule, with very
little bias41. The covalent adducts produced by the reaction of SHAPE reagents with RNA
are quantifiable by primer extension, similar to other chemical modifications or cleavage
products previously discussed. SHAPE was first applied to measure the flexibility of tRNA
nucleotides41, and was subsequently applied to study the structures of a range of transcripts,
from small riboswitch domains42, to a bacterial ribosome43, to an entire HIV-1 genome44,
and many others45–48.
SHAPE is now perhaps the only RNA structure probing strategy enabling robust
high-quality structure modeling for RNAs of realistic length. A three-reagent SHAPE
experiment provides sufficient information to allow the creation of structure models with
consistently greater than 90% correct base pairs40. Structure predictions are obtained by
minimizing a nearest-neighbor free energy model using the software RNAstructure with
SHAPE reactivities input as additional pseudo-free energies42.
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Figure 1.2: Reaction of SHAPE reagent with RNA. Shown is a simplified reaction
pathway of the SHAPE reagent 1-methyl-7-nitroisatoic anhydride (1M7) with RNA.
Flexible nucleotides sample conformations favorable to reaction with 1M7 more than
nucleotides that are conformationally constrained, leading to selective adduct formation
on single-stranded flexible nucleotides.
1.3 Massively parallel sequencing applied to RNA structure
1.3.1 Massively parallel sequencing technologies
The chain termination method of DNA sequencing, also called Sanger sequencing,
was first published in 197749. A labeled DNA primer is extended complementary
to a template strand by DNA polymerase. Small concentrations of chain-terminating
dideoxynucleotide triphosphates (ddNTPs) are included in four separate reactions, one
for each nucleotide, resulting in the formation of cDNA fragments that are resolved by
gel electrophoresis. The chain termination method has been streamlined using fluorescent
ddNTPs and capillary electrophoresis50, but is limited to generating sequences of about one
thousand nucleotides at a time. Methods that provide increased throughput by performing
hundreds of thousands of primer extension reactions in parallel have been critical to
genome-scale sequencing projects51.
One such approach is pyrosequencing, in which the incorporation of specific dNTPs is
detected as a luminescent signal from an enzymatic cascade. Pyrosequencing instruments
can generate about 100 million nucleotides of sequence information in a single run in a
single day52. A second popular approach uses fluorescent, reversible chain terminators to
extend primers against template DNA. Illumina instruments using this method are capable
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of generating billions of nucleotides of sequence in a single run53.
1.3.2 Previous reports linking parallel sequencing and RNA structure
Several groups have recently reported methods for probing RNA structure while
taking advantage of massively parallel sequencing technologies. These methods have
used SHAPE, other chemical probes, and enzymatic and hydroxyl radical footprinting
to measure RNA flexibility or solvent accessibility. Several of these methods have been
applied to the characterization of large-scale RNA structure trends in transcriptome studies.
SHAPE-Seq
A method combining SHAPE with parallel sequencing, SHAPE-Seq54, was reported
in 2011. Reverse transcription of SHAPE-modified RNA is performed using designed
primers, producing cDNA with known 5′ ends and stops corresponding to SHAPE
adduct sites. Known sequence adapters are added on the 3′ end by DNA-DNA ligation,
allowing polymerase chain reaction (PCR) amplification and sequencing. SHAPE-Seq was
demonstrated to allow the simultaneous probing of mutant RNAs in complex mixtures
in a single experiment. However, because it relies on designed primers for the initial
reverse transcription, this method is limited in practice to studying RNAs of several hundred
nucleotides, and not easily extended to transcriptome-scale experiments.
Enzymatic methods
Two methods for resolving enzymatic cleavage experiments are FragSeq55 and parallel
analysis of RNA structure (PARS)56, both reported in 2010. In the FragSeq method,
RNAs are treated with RNase P1, a nuclease that preferentially cleaves single-stranded
RNA. The resulting RNA fragments are then ligated to DNA adapters of known sequence,
followed by reverse transcription, PCR amplification, and parallel sequencing. Obtained
sequences are aligned to a reference sequence, and RNase cut site counts are compared with
undigested and polynucleotide kinase-treated controls. This method was demonstrated on
the transcriptomes of mouse embryonic stem cells and differentiated neural precursor cells,
8
primarily focusing on the structures of a small number of non-coding RNAs (ncRNAs)
shorter than 200 nucleotides. The PARs method is similar, using enzymatic cleavage
followed by adapter ligation, PCR, and sequencing. PARs, however, uses two RNases,
one that cleaves single-stranded regions, and one that cleaves helical (base-paired) regions.
PARs was applied to a yeast transcriptome, showing that untranslated regions (UTRs) tend
to be less structured than coding regions, and that translation start and stop codons tend to
be single-stranded. A three-nucleotide periodic trend in structure within coding regions was
also reported. When applied to human transcriptomes, PARs provided evidence that human
UTRs are overall more structured than human coding regions, and that natural sequence
variation changes RNA structure at thousands of sites between individuals57.
DMS probing
Three strategies for coupling DMS probing and massively parallel sequencing have
been reported to date: structure-seq58, DMS-seq59, and Mod-seq60. Structure-seq uses
random primers with known adapter sequence for reverse transcription of DMS-modified
or control RNA, producing cDNAs with known 5′ ends. 3′ adapters are then ligated to
the cDNA, allowing PCR amplification and sequencing. Sites of DMS modification are
detected as reverse transcription stops. DMS-seq and Mod-seq follow similar protocols,
with subtle differences in size selection and PCR steps designed to enrich for DNA
fragments resulting from DMS-induced reverse transcription stops. Structure-seq was
applied to RNA from Arabidopsis thaliana, a model plant species. This showed that A.
thaliana UTRs are more flexible than coding regions, that a short less-structured region
exists upstream of translation start codons, and that the first nucleotide in each codon of
highly-translated transcripts is on average more flexible than the second and third positions,
an effect not explained by sequence identity58. DMS-seq was applied to RNA from yeast
and cultured human cells, under in vivo, in vitro refolded, and denatured conditions. In
vitro refolded RNA appeared the least reactive (the most structured), while in vivo-modified
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RNA showed intermediate reactivity between in vitro and denatured. This evidence, along
with data from follow-up experiments, was interpreted to show the effects of both active
RNA helicases and passive RNA-binding proteins on RNA unfolding in cells59.
Hydroxyl radical footprinting
A recent report described a method for coupling hydroxyl radical footprinting and
massively parallel sequencing, called HRF-Seq61. This method uses reverse transcription
of cleavage products followed by adaptor ligation and PCR. HRF-Seq attempts to
rigorously account for PCR biases using randomized barcode primers and a computational
correction. HRF-Seq also corrects for variation in sequencing coverage, unlike the
previously mentioned methods, which assume uniform coverage. This is a critical
difference, as reverse transcription sequencing coverages often greatly vary over the length
of a given RNA.
Limitations
The methods described in this section have provided strong evidence for various global
trends in RNA structure. All these methods, however, share common weaknesses. First,
a single-stranded RNA-DNA or DNA-DNA ligation is one of the first steps after chemical
modification or cleavage in all these protocols. These reactions are inefficient and highly
biased by structure62. Second, with the possible exception of SHAPE-seq, none of these
methods provide true single-nucleotide resolution, as they use reagents or enzymes that
only react with a subset of the four nucleotides in RNA. Third, none of these methods
have been shown to produce consistently accurate secondary structure models, likely as a
consequence of the previous two limitations. For example, despite using over 80 million
reads mapping to ribosomal sequence, the initial structure-seq publication reported that the
inclusion of DMS probing data was unable to improve the modeling of the small subunit
of the yeast ribosome above 50% accuracy58 (for comparison, SHAPE data improve the
modeling accuracy of a bacterial ribosomal small subunit to 97%43). Furthermore, in the
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race to publish large-scale structural studies, some authors have included data in their
analyses with extremely low signal above background (see Section 3.4). The authors of
Mod-seq and SHAPE-seq have noted the importance of deep sequencing coverage and
statistical significance54,60.
1.4 Research overview
Chapter 2 describes my work applying SHAPE to study the structure of the mRNA
associated with the triplet repeat expansion disorder Huntington’s disease. I probed the
structure of five in vitro transcripts covering the first exon of huntingtin, including CAG
repeat regions from 17 to as long as 70 triplets. Chapter 3 describes ShapeMapper, a fully-
automated software data analysis pipeline that I developed to enable the extension of the
SHAPE strategy to larger scales using mutational profiling (MaP). Chapter 4 describes
a pilot study of the RNA structures present in the Escherichia coli transcriptome using
SHAPE-MaP, showing the power of both the mutational profiling strategy and the broad
utility of the ShapeMapper software.
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2 ROLE OF CONTEXT IN RNA STRUCTURE: FLANKING SEQUENCES
RECONFIGURE CAG MOTIF FOLDING IN HUNTINGTIN EXON 1
TRANSCRIPTS1
2.1 Introduction
Huntington’s disease (HD) is a devastating, ultimately fatal neurodegenerative
disorder. In healthy individuals, the first exon of each of the two alleles of the huntingtin
gene contains a relatively short region of CAG triplet repeats that encode polyglutamine;
the most common allele has 17 repeats. In HD patients, one huntingtin allele is abnormally
expanded to contain between 36 and 70 CAG repeats, although patient alleles with shorter
or significantly longer repeat regions have also been reported.1,2 The length of this HD-
expanded CAG-repeat region is inversely correlated with patient age at the onset of
symptoms, which include involuntary movements and dementia.2 Pathogenesis is due to the
polyglutamine peptides translated from the disease allele, and the expanded CAG repeat-
containing RNA transcripts may also be toxic.3,4
This study was motivated by the potential for allele-selective therapeutic targeting
of the huntingtin mRNA that might result if the RNA structure could be modeled with
confidence. Huntingtin is nearly universally expressed and appears to be especially
important for correct functioning of the adult nervous system.5-8 An ideal therapeutic
would therefore specifically destroy the disease-expanded huntingtin transcript or block
its translation while preserving the function of the healthy length transcript. Recent efforts
to selectively target the expanded huntingtin transcript have focused either on targeting
single-nucleotide polymorphisms associated with disease alleles9,10 or on targeting the
CAG repeats, taking advantage of the greater number of effective binding sites in the
1This chapter previously appeared as an article in Biochemistry. The original citation is as follows: Busan
S, Weeks KM. “Role of context in RNA structure: flanking sequences reconfigure CAG motif folding in
huntingtin exon 1 transcript,” Biochemistry 52, no. 46 (November 2013): 8219-25.
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expanded transcript.11 Allele-specific structures within the huntingtin mRNA could provide
additional, and more precise, targets for therapeutic development.
Biochemical studies have consistently demonstrated that RNA transcripts containing
CAG repeats fold into duplex helices and hairpins.12-15 CAG-containing duplexes have
been examined by NMR14 and X-ray crystallography.16 Recent studies have also shown
that flanking sequences can modulate triplet-repeat folding. The addition of even a short
region of flanking huntingtin sequence to CAG repeats results in the formation of more
complex structures.17 We therefore sought to determine the folded structures of huntingtin
transcripts with varying CAG repeat lengths in the context of the sequence of longer
transcripts, more closely resembling those found in cells.
We designed five transcripts covering the entire first exon of the huntingtin mRNA.
These exon 1 transcripts spanned the 5′ untranslated region (UTR), contained from 17
to 70 CAG repeats, and included the downstream region encoding polyproline repeats
(mostly CCG). A combination of SHAPE (selective 2′-hydroxyl acylation analyzed by
primer extension), RNase T1 cleavage, and targeted antisense oligonucleotide binding was
used to investigate the folded structures of these transcripts. We found that the sequence
context had profound effects on the folded structure of the transcript because CAG repeats
pair extensively with flanking huntingtin mRNA sequences. A CAG hairpin was absent or
short in huntingtin transcripts with repeat lengths typical of healthy individuals (17 and 23
repeats) but was present in transcripts with disease-associated numbers of repeats (36, 41,
and 70 repeats). Our data suggest that there are structural differences between healthy and
disease-inducing alleles that may be promising targets for therapeutic intervention.
2.2 Methods
2.2.1 Sequences, primers, and antisense oligonucleotides
The sequence of the huntingtin mRNA exon 1 transcript is as follows (n
= 17, 23, 36, 41, and 70): GCUGCCGGGA CGGGUCCAAG AUGGACGGCC
18
GCUCAGGUUC UGCUUUUACC UGCGGCCCAG AGCCCCAUUC AUUGCCC-
CGG UGCUGAGCGG CGCCGCGAGU CGGCCCGAGG CCUCCGGGGA CUGC-
CGUGCC GGGCGGGAGA CCGCCAUGGC GACCCUGGAA AAGCUGAUGA AG-
GCCUUCGA GUCCCUCAAG UCCUUC (CAG)n CAACAGCCGC CACCGCCGCC
GCCGCCGCCG CCGCCUCCUC AGCUUCCUCA GCCGCCGCCG CAGGCACAGC
CGCUGCUGCC UCAGCCGCAG CCGCCCCCGC CGCCGCCCCC GCCGCCACCC
GGCCCGGCUG UGGCUGAGGA GCCGCUGCAC CGACC. The reverse-transcription
primer is GGTCGGTGCAGCG, and the antisense oligonucleotides, listed by
the 5′-most target nucleotide in the 70-CAG huntingtin transcript (* indicates a
locked nucleotide(18)) are (1) *TCC*CGG*CAG*C, (159) *ATC*AGC*TTT*T,
(431) *AGG*AGG*CG*GCG*GCG*G, (464) *GTG*CCT*GCG*G, and (475)
*TGA*GGC*AG*CAG*CGG*C.
2.2.2 Transcript production and purification
Plasmids contained huntingtin sequences, a T7 promoter at the 5′ end, and a Bts
I restriction site at the 3′ end and were obtained by de novo synthesis (Blue Heron
Biotechnology). Cells (SURE 2, Agilent Technologies) were transfected with plasmid, and
500 mL cultures were prepared. Plasmids were extracted, and constructs were verified by
sequencing. Plasmids were linearized with Bts I (New England Biolabs), and linearization
was confirmed by agarose gel electrophoresis. Linearized template sequences were
transcribed using T7 RNA polymerase, and products were separated by polyacrylamide
gel electrophoresis, excised from the gel, and recovered by precipitation with ethanol.19
Transcripts were resuspended at 0.25 M in 1/2 TE buffer, aliquoted for single use, and
stored at 20◦C.
2.2.3 In vitro transcript folding, SHAPE, and RNase T1 probing
Transcripts were denatured at 95◦C for 2 min, snap-cooled on ice for 2 min, and
refolded at 37◦C for 30 min in 50 mM Tris-HCl (pH 8), 75 mM KCl, and 3 mM MgCl2.
19
SHAPE probing was performed using 58 mM final concentration 1-methyl-7-nitroisatoic
anhydride (1M7) for 5 min at 37◦C.20 Enzymatic cleavage was carried out using RNase
T1 (Ambion) at a final concentration of 0.2 U/L for 5 min at 37◦C. Transcripts were
recovered by ethanol precipitation. SuperScript III reverse transcriptase (Invitrogen) was
used to extend the fluorescently labeled reverse-transcription primer (above) for 1 h at
37◦C. Fluorescent cDNA fragments were quantified using capillary electrophoresis.21
2.2.4 Structure disruption using antisense oligonucleotides
Transcripts were combined with five pooled antisense oligonucleotides (ASOs),
containing locked nucleotides (Exiqon) to enhance RNA binding, at a 4-fold excess of
each ASO over RNA. Transcripts were then denatured, snap-cooled, folded, and modified
as described above. To reduce the concentration of ASOs prior to reverse transcription,
transcripts were incubated with three DNA oligonucleotides complementary to ASOs 431,
464, and 475 at a high concentration (200 times that of the RNA) at 95◦C for 2 min. Three
serial rounds of binding, washing, and elution (RNeasy MinElute columns, Qiagen) were
then performed to remove the ASOs and their complements. Structure analysis by reverse
transcription was performed as outlined above.
2.2.5 Electropherogram analysis and structure prediction
Electropherograms were analyzed with QuShape.21 SHAPE data were analyzed as
follows: nucleotides with no-reagent signals above the 99th percentile in any trial were
excluded from analysis in all transcript data sets. SHAPE reactivity profiles were
normalized as described,22 except that the CAG-repeat region was excluded from the
normalization calculation to maintain a consistent SHAPE reactivity distribution across all
transcripts. RNase T1 data were analyzed as follows: nucleotides with background signals
in the top 3% were excluded. Background and plus-RNase signals were normalized to
the median of the plus-RNase signal. After background subtraction, guanosine residues
showing normalized intensity values between 1 and 2 were designated low cleavage,
20
between 2 and 4, medium cleavage, and above 4, high cleavage.
Secondary structures were modeled using the Fold module of RNAstructure,23 version
5.4, using the latest parameters for incorporating SHAPE data.24,25 Because the huntingtin
mRNA likely forms many noncanonical base pairs and contains multiple regions of
repeated sequence, structure modeling was challenging. Without constraining secondary-
structure models with SHAPE data, RNAstructure predicted a large number of alternative
structures of similar energy. SHAPE constraints brought these predictions into agreement
with experimental data and significantly reduced the number of plausible structures. Given
the overall similarities in nucleotide reactivities across the five transcripts (Figures 2.1, 2.3,
and 2.5), the lowest predicted free-energy structure for the shortest transcript was used as
a template to select the most likely structure for each of the CAG-expanded transcripts.
In addition, we selected those structural models that showed reactive nucleotides in the
CAG-repeat region within two triplets of a CAG hairpin terminus.
2.3 Results
2.3.1 SHAPE and RNase probing of huntingtin exon 1
We used SHAPE26,27 chemical probing to analyze the structure of five RNA transcripts
containing shorter CAG-repeat lengths (17 and 23 repeats) typical of healthy alleles and
longer, disease-associated, numbers of repeats (36, 41, and 70 repeats). Little degradation
of RNAs was observed as judged by the low peak intensities in reverse-transcription
products from the no-reagent controls, as analyzed by capillary electrophoresis. SHAPE
reactivity profiles for each of the transcripts are shown split in the center of the CAG-repeat
region and aligned at the 5′ and 3′ ends (Figure 2.1). Overall, SHAPE reactivity profiles
for the five transcripts are highly similar, suggesting that the global secondary structure
is not affected by expanded CAG repeats (Figure 2.1). Within the CAG-repeat region in
each transcript, most nucleotides were unreactive, consistent with formation of stable base
pairing.26,27 In addition, within each CAG repeat region, there was a short region with
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more reactive (conformationally flexible) nucleotides; this region was not centered in the
CAG-repeat region but instead was offset in the 3′ direction (Figure 2.1, emphasized with
solid arrows). This asymmetry in the CAG-repeat regions was also observed by RNase T1
enzyme probing (Figure 2.5). The group of SHAPE-reactive nucleotides was consistently
located six triplets 3′ of the center of the poly-CAG repeat.
2.3.2 Structural models of huntingtin transcripts
We used the SHAPE data to develop experimentally supported24,25 models for
thermodynamically accessible states for each of our huntingtin RNA transcripts. The 5′
UTR and 3′ regions of the RNAs are predicted to form similar or identical structures,
independent of CAG-repeat length (Figure 2.2). In general, these structural models are
well-defined (Supporting Information Figure 2.2). These models, which are based on
RNA transcripts with long flanking sequences, likely capture features relevant to huntingtin
mRNA structure in vivo. The 5′ end corresponds to the transcription start site 145
nucleotides from the translation start, although transcripts starting at 135 may also be
present in vivo.28,29 Some end effects are possible because of truncation of the studied
transcripts at the 3 exon boundary (155 nucleotides from the CAG-repeat region).
Strikingly, the CAG repeat region forms extensive base-pairing interactions with
nucleotides outside the repeat region (Figures 2.2 and 2.6, CAG repeat sequences are
highlighted in orange). The 5′ end of the UTR, the CCG-repeat region immediately
downstream of the CAG-repeat region, and an 11-nucleotide region with the sequence
GCCGCUGCUGC (perfectly complementary to CAG repeats apart from one A:C
mismatch) are all predicted to base pair with CAG-repeat nucleotides. The remarkable
result of this base pairing is that a hairpin formed only of CAG-repeat nucleotides is entirely
absent from the model of the healthy huntingtin transcript that contains 17 CAG repeats
(Figure 2.2, left). Moreover, the CAG-repeat hairpin and the three-helix junction from
which it extends represent allele-specific structures that occur preferentially in the longer
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Figure 2.1: SHAPE profiles for huntingtin exon 1 transcripts as a function of CAG-
repeat length. Reactivity profiles are shown split in the center of the CAG repeat region
and aligned at the 5′ and 3′ ends. The black, yellow, and red scale indicates low, medium,
and high SHAPE reactivities, respectively. The most SHAPE-reactive region within the
CAG repeat consistently falls six CAG repeats 3′ of the CAG-repeat-region center, as
emphasized with solid arrows. The region likely to form an internal loop in the 17-CAG
repeat transcript is indicated with an asterisk (top panel). Data shown are the average
of three independent experiments. The small number of nucleotides for which no data
were obtained (because of strong electropherogram peaks in the no-reagent control, see
Methods) are marked with gray boxes on the x axis.
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Figure 2.2: Structural models for representative normal and disease-associated
huntingtin transcripts. Secondary-structure models for the most common healthy length
transcript (17-CAG) and for a strongly disease-associated (41-CAG) RNA are shown.
SHAPE and T1 RNase probing are shown with colored nucleotides and arrowheads,
respectively. The absence of a CAG hairpin in the 17-CAG repeat RNA is emphasized
with an asterisk.
disease-associated alleles.
2.3.3 CAG hairpin induction
If base pairing between CAG repeats and flanking sequences prevents CAG hairpin
formation in healthy-length huntingtin transcripts, disrupting this base pairing should allow
the RNA to refold and form extended hairpins (Figure 2.3, left). We folded all five
huntingtin transcript RNAs in the presence of five antisense oligonucleotides designed to
bind sequences flanking the CAG repeats and to compete for base pairing with these non-
CAG sequences. Under these conditions, SHAPE-reactive nucleotides occurred at or near
the center of the CAG-repeat element in all transcripts, both healthy length and disease
expanded (Figure 2.3, right, site of hairpin loop is emphasized with open arrow). Thus,
CAG-repeat elements can be forced to form a simple hairpin structure by inhibiting pairing
to flanking sequences present in the native transcript.
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Figure 2.3: SHAPE analysis of huntingtin transcripts in the presence of antisense
oligonucleotides designed to disrupt pairing between CAG sequences and flanking
regions. Five antisense oligonucleotides were designed to bind specific, non-CAG
sequences in the huntingtin mRNA to disrupt base pairing with the CAG-repeat region
and to promote formation of a CAG hairpin. Oligonucleotide binding sites are shown with
black bars. The center (reactive) region of each CAG-repeat element is emphasized with an
open arrow and is consistent with simple hairpin formation by self-paired CAG sequences.
2.4 Discussion
Our work provides the first empirical examination of huntingtin mRNA structure in the
context of extended, native flanking sequences (in this case, the entire first exon). Given the
GC-rich nature of the huntingtin mRNA, it is not surprising that the transcripts are highly
structured (Figure 2.2). The CAG-repeat regions adopt distinct structures that depended
on repeat length and on the flanking sequence context (Figure 2.4). In the absence of
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interacting flanking sequences, poly-CAG transcripts, which are found in several disease-
related contexts,30,31 fold back on themselves to base pair into simple hairpins.12,13 In
huntingtin exon 1 mRNA sequences, CAG repeats are followed by poly-CCN sequences
and a complementary GCCGCUGCUGC sequence, and our analysis indicates that these
flanking sequences pair with the poly-CAG element. Because CAG repeats base pair with
flanking sequences, a CAG hairpin was not observed in the transcript containing the 17
CAG repeats typical of a healthy individual.
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Cellular and animal models of HD indicate that disease symptoms correlate with
several factors including repeat lengths, expression levels, localization of huntingtin
transcripts, truncation of the huntingtin sequence, and stoichiometry of native and
mutant sequences.32-34 This work supports the hypothesis that the CAG-repeat-containing
transcript itself, and not just its ability to encode polyglutamine, might be important
for disease etiology. The two widely used mouse models of HD employ a yeast
artificial chromosome (YAC128)35 or a bacterial artificial chromosome (BACHD).36
26
Despite expressing similar mutant huntingtin mRNAs, BACHD mice do not show
aggregate formation or display the transcriptional dysregulation present in YAC128 mice
and HD patients.37 An important distinction between these models is the use of nearly
pure CAG repeats in YAC128 versus unnatural, mixed CAA/CAG repeats in BACHD.
The presence of CAA triplets disrupts extended hairpin formation and favors branched
secondary structures.38 In addition, CAA sequences will not base pair strongly with
CCG sequences and other flanking regions present in the authentic huntingtin transcript
sequence. The allele used in the BACHD model will almost certainly lack the striking
CAG-repeat-length-dependent hairpin formation found in this study; therefore, some of
the phenotypic differences that distinguish pure CAG from mixed-codon HD models may
reflect differences in RNA structure.
The secondary-structure models developed in this work also suggest specific roles
for huntingtin mRNA structure in splicing and translation. First, expanded CAG repeats
within huntingtin transcripts contribute to misregulation of splicing. These defects include
sequestration of the splicing factor muscleblind-like protein 117,39 and mis-splicing of the
huntingtin transcript, possibly because of recruitment of the splicing factor SRSF6.40 We
hypothesize that base pairing by healthy-length CAG repeats to flanking sequences reduces
deleterious recognition by splicing factors. Second, the huntingtin 5′ UTR and the region
surrounding the primary translation start site form stable RNA structures (Figure 2.2); in
general, structured UTRs reduce translation initiation.41 Taken together with a putative
active upstream open reading frame in huntingtin,29 this work suggests that regulation of
huntingtin translation may be complex and involve the interplay of the general translation-
initiation machinery, contributions of strong local structure at the translation-initiation site,
and the possible presence of multiple initiation sites.
The absence of a CAG hairpin in short, healthy-length huntingtin transcripts and
its presence in transcripts with increased numbers of repeats suggests that allele-specific
27
targeting of huntingtin mRNA structures will be possible. SHAPE-directed structure
models suggest that CAG hairpins occur in disease-associated alleles but not in alleles
with fewer repeats characteristic of healthy individuals. Molecules that bind specifically to
CAG hairpins, especially if they discriminate against duplexes in which CAG sequences
pair with CCG repeat sequences (Figure 2.2), are likely to be very selective for disease-
causing alleles. The three-helix junction from which the CAG hairpin extends represents
another novel RNA target with the potential for both gene and allele selectivity. Broadly,
our findings highlight the importance of flanking sequence in RNA folding and hint at
the insights to be gained by conducting quantitative, large-scale RNA-structure analyses.
Examinations of the effects of context on RNA structure are likely to identify new
therapeutic targets in repeat-expansion diseases.
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Figure 2.6: Secondary structure models for 23, 36, and 70-CAG repeat length
huntingtin exon 1 transcripts. Structure and reactivity annotation scheme is the same
as shown in Fig. 2.2.
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Figure 2.7: Plausible competing structures for long CAG repeat sequences.
Representative structures are shown in the context of the 41-CAG transcript.
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3 SOFTWARE FOR THE AUTOMATED ANALYSIS OF SHAPE AND
MUTATIONAL PROFILING (SHAPE-MAP) DATA1
3.1 Introduction
SHAPE is unique among RNA structure probing strategies because it reports on
the flexibility of all four ribonucleotides and enables highly accurate secondary structure
modeling1–3. However, in its original capillary electrophoresis version it is limited by
signal fall-off to about 500 nucleotides in a single experiment4, and often requires skilled
users to process the data and create reactivity profiles5,6. The mutational profiling (MaP)
strategy was developed to allow the streamlined application of SHAPE to large RNAs and
multiple RNAs in single experiments and the full automation of data analysis.
3.2 SHAPE-MaP strategy
In the SHAPE-MaP strategy, reverse transcription is performed in the presence of a
high (6 mM) concentration of Mn2+. This causes a slight decrease in reverse transcription
fidelity overall, but a highly useful reduction in fidelity specifically at SHAPE adduct
sites. As a result, SHAPE adduct locations are encoded as sequence mutations in the
cDNA library (Figure 3.1). In a SHAPE-MaP experiment, two control libraries are also
prepared, one from RNA exposed to solvent but no SHAPE reagent (a background control),
and one from RNA exposed to SHAPE reagent under highly denaturing conditions (an
adduct detection rate control). Mutation rates from the three total samples are compared
to produce final reactivity profiles (Figure 3.2, panels A and B), which agree closely with
known secondary structures (Figure 3.2, panel C). Importantly, directed primers or random
primers7 can be used in reverse transcription, allowing the probing of large RNAs in single
1This chapter previously appeared in extended form as an article in Nature Methods. The original citation is
as follows: Siegfried, N.A., Busan, S., Rice, G.M., Nelson, J.A.E. & Weeks, K.M. RNA motif discovery by
SHAPE and mutational profiling (SHAPE-MaP). Nat. Methods 11, in press (2014).
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experiments.
SHAPE-MaP’s ability to accurately report nucleotide-resolution RNA flexibility and
to enable accurate secondary structure prediction was extensively validated. SHAPE-MaP
was also applied to the discovery of new structured motifs in an HIV-1 genome. This work
was primarily performed by Nate Siegfried and Greggory Rice, and is described in detail
in the first SHAPE-MaP publication8.
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SHAPE modification
Mutational Profiling (MaP)
Library preparation & sequencing
Mutation counting
Structure modeling
folded
RNA
SHAPE adducts
RNA
dsDNA
SHAPE adduct
adduct-induced
mutationMn2+
cDNA
SHAPE profile
Figure 3.1: SHAPE-MaP overview. RNA is treated with a SHAPE reagent that
reacts at conformationally dynamic nucleotides9. Reverse transcription is carried out
under conditions such that the polymerase reads through chemical adducts in the RNA
and incorporates a nucleotide non-complementary to the original sequence (in red) into
the cDNA. The resulting cDNA is sequenced using any massively parallel approach to
create mutational profiles (MaP). Sequencing reads are aligned to a reference sequence,
and nucleotide-resolution mutation rates are calculated, corrected for background and
normalized, producing a standard SHAPE reactivity profile. SHAPE reactivities can then
be used to model secondary structures, visualize competing and alternative structures, or
quantify any process or function that modulates local ribonucleotide dynamics.
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Figure 3.2: Nucleotide-resolution interrogation of RNA structure. (A) Mutation rate
profiles for the SHAPE modified and untreated thiamine pyrophosphate (TPP) riboswitch
RNA in the presence of ligand (top) and for SHAPE modification performed under
denaturing conditions (bottom). (B) Quantitative SHAPE profile obtained after subtracting
the data from the untreated sample from data for the treated sample and normalizing by the
denatured control. (C) SHAPE reactivities plotted on the accepted secondary structure of
the ligand-bound TPP riboswitch10. Red, orange, and black correspond to high, moderate,
and low reactivities, respectively.
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3.3 SHAPE-MaP data analysis pipeline (ShapeMapper)
I created a data analysis pipeline, called ShapeMapper, that can be executed on
most unix-based platforms and accepts as input sequencing read files in FASTQ format,
reference sequences in FASTA format, and a user-edited configuration file. Without further
user intervention, the software creates a SHAPE reactivity profile and standard error
estimates for each reference sequence (Figure 3.3). Other useful outputs are provided
including mutation counts, sequencing depths, and predicted secondary structures. The
analysis software incorporates several third-party programs. Python 2.7 is required11;
Bowtie 2 is used for read alignment12; reactivity profiles are generated using the python
library matplotlib13; secondary structure prediction uses RNAstructure14; and secondary
structure drawing uses the Pseudoviewer web service15.
3.3.1 Configuration
A configuration file is used to specify the reference sequences present in each sample
and which samples should be combined to create reactivity profiles (Figure 3.3, panel A).
The format is flexible, allowing the alignment of each sample to multiple sequence targets
as well as the treatment of multiple samples in unified analyses. Important parameters for
each stage of analysis may also be customized.
3.3.2 Quality trimming
Input reads are separated into files by sequencing barcode (this step is integrated into
most sequencing platforms)16. The first analysis stage trims reads by base-call quality.
Each read is trimmed downstream of the first base-call with a phred quality score below 10,
corresponding to 90% expected accuracy17. Reads with 25 or more remaining nucleotides
are copied to new FASTQ files for alignment.
3.3.3 Read alignment
Reads are locally aligned to reference sequences using Bowtie 212 (Figure 3.3,
panel B). Parameters were chosen to provide high sensitivity, to detect single nucleotide
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Figure 3.3: ShapeMapper software overview. Outline of software pipeline that fully
automates calculations of per-nucleotide mutation rates, SHAPE reactivities, and standard
error estimates given massive parallel sequencing data and at least one reference sequence.
The software is executable on most unix-based platforms.
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mismatches, and to allow deletions of up to about 200 nucleotides. Seed length (-L) is
15 nucleotides. One mismatch is allowed per seed (-N). Maximum seed attempts (-D) is
set at 20. Maximum re-seed attempts (-R) is set at 3. Dynamic programming padding (--
dpad) is set at 100 nucleotides. The match bonus (--ma) is 2. The maximum and minimum
mismatch penalties (--mp) are 6 and 2, respectively. Gap open and extend parameters (-
-rdg, --rfg) are 5 and 1, respectively. The default minimum alignment score function is
used. Soft-clipping is turned on. Paired-end alignment is used by default. Bowtie 2 outputs
aligned reads as SAM files.
3.3.4 Alignment parsing, ambiguous alignment removal, and mutation counting
In this stage, aligned reads are ultimately processed into mutation counts (Figure
3.3, panel C). Paired-end reads in SAM files are combined, and higher-quality base-calls
are selected where read pairs disagree. Mismatches and deletions contribute to mutation
counts; insertions are ignored. Since error-prone reverse transcription generates most of the
mutations in each read18, I treat a sequence change covering multiple adjacent nucleotides
as a single mutation event located at the 3′-most nucleotide. If random primers are used,
a region one nucleotide longer than the length of the primer is excluded from the 3′end of
each read. Reads with reported mapping qualities less than 30 are excluded, corresponding
to an estimated probability of greater than 0.1% that a given read originated from a different
location19.
Deletions are an important part of the mutation signal, but deletions that are
ambiguously aligned can blur this signal, preventing single-nucleotide resolution. To
resolve this problem, a simple local realignment is performed to identify and remove
ambiguously aligned deletions. The reference sequence surrounding a deletion is stored
(Figure 3.4, panel A). The deletion is then slid upstream or downstream one nucleotide
at a time to a maximum offset equal to the deletion length (Figure 3.4, panel B). At each
offset, the surrounding reference sequence is compared to the stored sequence. If any
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offset sequence matched, this indicates a possible alternate alignment, and the deletion
is excluded. This algorithm correctly identifies ambiguous deletions in homopolymeric
regions as well as repeated sequences (Figure 3.5).
Reference sequence:
CCTTCAACCTCTTCCGCCTCCTCACGCGAGACCTG
Read aligned to reference (deletion in dashes): 
CCTTCAACCTCTTCCG---CCTCACGCGAGACCTG 
Deletion locally relocated:
CCTTCAACCTCTT---CCTCCTCACGCGAGACCTG 
CCTTCAACCTCTTC---CTCCTCACGCGAGACCTG
CCTTCAACCTCTTCC---TCCTCACGCGAGACCTG 
--- 
CCTTCAACCTCTTCCGC---CTCACGCGAGACCTG 
CCTTCAACCTCTTCCGCC---TCACGCGAGACCTG
CCTTCAACCTCTTCCGCCT---CACGCGAGACCTG 
* Alternate valid deletion placements found.
Sequence surrounding deletion 
CCTTCAACCTCTTCCGCCTCACGCGAGACCTG 
Sequences surrounding relocated deletions
CCTTCAACCTCTTCCTCCTCACGCGAGACCTG
CCTTCAACCTCTTCCTCCTCACGCGAGACCTG
CCTTCAACCTCTTCCTCCTCACGCGAGACCTG
CCTTCAACCTCTTCCGCCTCACGCGAGACCTG *
CCTTCAACCTCTTCCGCCTCACGCGAGACCTG *
CCTTCAACCTCTTCCGCCTCACGCGAGACCTG *
A
B
Figure 3.4: Ambiguously aligned deletion identification. Demonstration of the
ambiguously aligned deletion detection algorithm applied to a single read. Nucleotides
in red show sequence differences compared to the initial sequence surrounding the
deletion. All-green sequences are identical to the initial sequence surrounding the deletion,
indicating alternate valid deletion placements. In this case, the existence of a duplicated
CCT sequence means four alignment locations are possible for a triplet deletion, making
unambiguous placement impossible. This deletion would be excluded from mutation
counting.
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Figure 3.5: Removal of ambiguously aligned deletions. Representative reactivity
profiles showing the effects of including or removing ambiguously aligned deletions. The
nucleotide highlighted with an orange arrow shows an increased reactivity when ambiguous
deletions are included. Data shown is from the 16S rRNA3 (MaP experiments performed
by Greggory Rice.)
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3.3.5 Reactivity profile creation
The mutation rate (mutr) at a given nucleotide is simply the mutation count
(mismatches and unambiguously aligned deletions) divided by the read count at that
location. Raw reactivities are generated for each nucleotide using the following expression,
where S corresponds to a SHAPE modified sample, U to untreated, and D to reaction under
denaturing conditions:
R = mutrS−mutrUmutrD (1)
The standard error (stderr) associated with the mutation rate at a given nucleotide in the S,
U, or D samples is calculated as:
stderr =
√
mutr√
reads
(2)
The final standard error of the reactivity at a given nucleotide is:
SE =
√
( stderrSmutrD )
2 +( stderrUmutrD )
2 +(stderrD× (mutrS−mutrU )mutr2D )
2 (3)
Reactivities are normalized to a standard scale that spans zero (no reactivity) to 2 (high
SHAPE reactivity) as described20. Nucleotides with mutation rates greater than 5% in
untreated control samples are excluded from analysis, as are nucleotides with sequencing
depths less than 10 in any sample.
3.3.6 Final data output
ShapeMapper automatically produces figures showing SHAPE reactivity profiles and
standard errors (Figure 3.3, panel D, and Figure 3.6). SHAPE reactivity profiles are also
output as tab-delimited text files (.shape) with the first column indicating nucleotide number
and the second reactivity. A SHAPE-MaP reactivity file is also output (.map). This file is
in the SHAPE file format with the addition of two columns: standard error and nucleotide
sequence. Another file (.tab) containing mutation counts, read depths, mutation rates, raw
reactivities, normalized reactivities, and standard errors for SHAPE modified, untreated,
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and denatured samples is also created. Files containing figures showing mutation rate
histograms, sequencing depths, and reactivity profiles are generated (.pdf). These are useful
in diagnosing potential experimental problems, including insufficient sequencing depth or
low mutagenesis efficiency (Figure 3.7).
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Figure 3.6: Example reactivity profile. Shown are the SHAPE reactivities obtained for
the 6S RNA from E. coli – see chapter 4 for more details on this experiment. Error bars
show standard error as calculated from equation (3).
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A B 
Figure 3.7: Example histograms and troubleshooting. (B) Successful MaP experiment.
Read depths for all samples are largely above the nominal recommended level of 5000.
Mutation rates in the +reagent condition are above background. The majority of the
reactivities are positive. (B) Failed MaP experiment. Background mutation rates are
unusually high, and mutation rates in the +reagent condition are not above background.
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3.3.7 Automatic RNA folding and structure drawing by ShapeMapper
For sequences shorter than 4000 nucleotides and with sufficient read depth,
the automated pipeline allows secondary structures to be automatically modeled using
RNAstructure (Figure 3.3, panel E). FASTA sequence files are converted to SEQ files
required by RNAstructure. SHAPE reactivities are incorporated into RNAstructure as
pseudo-free energies using standard parameters for the 1M7 reagent20 [slope (-sm) 1.8,
intercept (-si) -0.6]. Predicted structures are written to .ct files. The lowest energy predicted
secondary structures can be drawn and annotated by SHAPE reactivity (Figure 3.8).
This stage queries the Pseudoviewer web service15,21 over an active internet connection.
A custom client (pvclient.py) internally converts connect-table22 (.ct) structures to dot-
bracket notation, submits server requests, and retrieves responses. This client also handles
coloring of nucleotides by reactivity. Colored structure drawings are vector .eps files.
Structures are also automatically converted to .xrna files23 for optional manual editing.
Additional options for rendering multiple structures and customizing coloring are available
if this client is executed manually.
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Figure 3.8: Example structure drawing and coloring. The Pseudoviewer web service15
is automatically queried with a secondary structure. (A) Postscript24 image generated
by Pseudoviewer. (B) Postscript image with automatic annotation by SHAPE reactivity
coloring.
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3.4 Hit level calculation and comparison with other reports
SHAPE-MaP structure analysis as read out by massively parallel sequencing presents
a valuable tool for structural interrogation of RNA bases at a single nucleotide level.
Several other techniques have been developed with similar goals25–30. To compare the
read depth requirement of SHAPE-MaP (and its mutational profiling readout) with other
approaches, we calculated a “hit level”. The hit level metric quantifies the total background-
subtracted signal per nucleotide of transcript:
hit level =
total eventsS− read depthSread depthB×total eventsB
transcript length (7)
where the subscripts S and B indicate the experimental sample and background control,
respectively; events are either ligation-detected sequence stops or mutations, depending on
readout method, and read depth corresponds to the median number of reads overlapping
each nucleotide in the transcript. A hit level of 15 is required to fully recover RNA
structure information as interrogated by SHAPE, although highly useful structure models
were consistently obtained at hit levels as low as 58. In SHAPE-MaP experiments, we often
obtained hit levels greater than 100. For example, we obtained a hit level of 160 for the
16S rRNA (experiment performed by Greggory Rice).
High-resolution RNA structure probing and modeling requires that most or all of
an RNA be interrogated at a high hit level. Individual regions probed at low hit levels,
even if the overall average hit level is 5, are likely to contain notable errors. In PARS
experiments, a minimum threshold of 1 average read stop per nucleotide of transcript
was required25,26 corresponding to hit level of 1, assuming zero background for enzymatic
cleavage data. Similarly, a report describing DMS chemical probing, structure-seq, used a
similar threshold of 1 average stop per A or C nucleotide27; this corresponds to an estimated
hit level (by our definition) of 0.2, assuming a signal:background ratio of 1.7 (estimated
from Extended Data Fig. 1, panel D in ref. 26) and that half of all transcript nucleotides
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are A or C. A minimum of 15 reads per A or C on average was required by the creators of
DMS-seq28. This corresponds to a hit level of 3.3, assuming a signal:background ratio of
1.8 (estimated from Fig. 1, panel C in ref. 27). The authors of SHAPE-seq29 and Mod-
seq30 have independently noted the importance of read depth in obtaining quantitative RNA
structure probing information.
This hit level analysis emphasizes that, although several prior studies have been
performed in which the full complement of RNAs in a given transcriptome were present
during the probing phase of the experiment, only a few thousand nucleotides in each case
were sampled at a depth consistent with recovery of the underlying structure information
obtainable using DMS or enzyme probes.
3.5 Conclusion
SHAPE-MaP and the software ShapeMapper have now been extensively validated on
RNAs of known structure. E. coli ribosomal RNAs have been structurally probed, as well as
small structured RNAs including RNase P, the HCV internal ribosomal entry site, a group
I intron, a group II intron, a phenylalanine tRNA, and the adenine, glycine, lysine, Mbox,
thiamine pyrophosphate, and cyclic-di-GMP riboswitches2. The SHAPE-MaP strategy
has been applied to characterize the structures of diverse viral RNAs, including HIV-18,
hepatitis C, satellite tobacco mosaic, and Dengue. ShapeMapper allows any lab to generate
accurate SHAPE data, eliminating user bias and reducing data analysis workload. SHAPE-
MaP yields accurate and high-resolution secondary structure models and will ultimately
democratize RNA structure analysis.
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4 HIGH-RESOLUTION MAP OF AN E. COLI TRANSCRIPTOME
4.1 Introduction
The successful development of SHAPE-MaP made accurately mapping transcriptome-
scale RNA flexibility a feasible experiment, with the ultimate goals of locating functional
RNA structures with low free energies of folding and determining global trends in
RNA structure. Several groups have reported RNA structure probing results from
transcriptomes1–4, but very few or none have achieved adequate signal over background
over large numbers of nucleotides (see Section 3.4). In addition, none have demonstrated
consistently accurate structure modeling. In contrast, the SHAPE-MaP strategy both
estimates the variation in the signal and enables accurate structure modeling. For these
reasons, SHAPE-MaP was an ideal strategy to apply to the structures formed in a bacterial
transcriptome.
4.2 Experimental Methods
Cell growth, SHAPE probing, and sequencing library preparation were performed by
Christopher Leonard. SHAPE probing and library preparation were performed according
to the strategies detailed in (Siegfried, N. et al., 2014)5, with the addition of a ribosomal
RNA depletion step.
Briefly, E. coli DH5α cells were grown to mid-log phase in Luria broth. RNA was
extracted by three serial phenol:chloroform extractions, followed by DNase I treatment
(Ambion) according to the manufacturer’s recommended protocol. Ribosomal RNAs were
depleted using a Ribo-Zero kit (Epicentre). RNA was purified and concentrated using an
RNeasy kit (silica membrane spin columns, Qiagen).
RNA for the untreated and SHAPE samples was refolded in vitro in the presence
of 100 mM HEPES, pH 8.0, 100 mM NaCl, and 10 mM MgCl2. RNA in the SHAPE
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sample was modified in the presence of 10 mM 1M7 at 37 ◦C for 3 minutes. The untreated
sample was incubated with solvent at 37 ◦C for 3 minutes. The denatured sample RNA was
modified with 1M7 under strongly denaturing conditions: 50 mM HEPES (pH 8.0), 4 mM
EDTA, and 50% formamide at 95 ◦C.
RNA was fragmented5, and reverse transcription primer extension was performed
using random dodecamers with SuperScript II (Invitrogen) in the presence of 6 mM Mn2+.
Sequencing library preparation was performed using TruSeq adapters, and the library was
sequenced on a HiSeq instrument (Illumina), using 100-nucleotide paired end reads.
4.3 Software for transcript calling and curation
I developed a simple software program for locating transcript boundaries in the
transcriptome dataset. Transcript boundaries were first called automatically, then manually
curated in a graphical environment (Figure 4.1).
4.3.1 Automated transcript calling
The automated calling of transcript bounds based on sequencing read depths required
an estimate of the distribution of read depths over any given transcript in the absence of
transcript edges. The distribution of read depths over a single transcript was ultimately
modeled as a normal distribution centered at 1 with a standard deviation of 0.431. This
distribution was estimated by extracting read depth profiles for all coding regions with
median depths greater than 2000. Coding regions (genes) were chosen as a proxy for
transcripts, since coding regions are unlikely to contain discontinuities from transcription
start and stop sites. The per-gene depth profiles were normalized to their respective median
depths, and combined to give the final distribution.
For individual transcript calls, a local maximum depth was chosen. The upstream and
downstream boundaries on the transcript were simultaneously incremented until the depths
at both edges met the condition:
localMedian−depthedge > m∗ stdevmodel ∗ localMedian (1)
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where localMedian is the median of the depths in a 150-nucleotide window nearest to the
current boundary (upstream or downstream), depthedge is the depth at the current boundary,
stdevmodel is 0.431, and m is a multiplier allowing the selection of various confidence
intervals. For automated calls, m was set to 1.96, corresponding to a confidence interval of
95%.
Initial transcript calls were generated by selecting the nucleotide with the highest
depth, choosing transcript boundaries by the algorithm above, and repeating until no un-
called nucleotides existed with depths above 1000.
4.3.2 Transcript call curation
Transcript calls were manually curated using a graphical environment (Figure 4.1)
designed and implemented in python using the matplotlib library. The program displays
four rows of information (from top to bottom): the boundaries of existing automated
transcript calls, the base-ten logarithm of the untreated sample read depth, the boundaries
and strands of annotated genes, and the boundaries and strand of EcoCyc-annotated
transcripts6.
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Figure 4.1: Transcript call curation. Screenshot of user interface for transcript boundary
curation. Existing transcript annotations from EcoCyc6 are shown on the bottom track.
Vertical edges on these shapes indicate known transcription start sites or terminators.
Transcripts and genes on the sense strand are shown in red, and those on the reverse strand
in blue. Median coverage depths for curated transcripts are shown in blue text.
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Transcription units were extracted from the EcoCyc database using queries in the Lisp
language and written to simplified text files for loading and display within the graphical
environment. Existing database transcript annotations are helpful, but incomplete7. Semi-
automated transcript calling is therefore available within the program by clicking on a
nucleotide in the depth profile. The value of m in equation (1) above can be manually set
to any value. Any visible boundary (from EcoCyc annotations, gene coordinates, existing
transcript calls, or interactive transcript calls) may be selected and written to file.
Reactivity files were created for each transcript call, containing genome coordinates,
nucleotide sequence, SHAPE reactivities, and reactivity standard errors. These files
also contain automatically generated warning messages for potential overlap with nearby
transcripts, unclear transcript boundaries, or errors of transcript sense. A total of 562
transcripts were called.
4.3.3 Depth requirements
A sequencing read depth of 5000 was required for consistently accurate structure
prediction in bootstrapped simulations of 16S rRNA modeling5. In transcript calling, I
required that transcripts have a median untreated read depth of above 1000, since lower-
quality reactivity profiles might still be useful for assessing global RNA flexibility trends.
For transcriptome-wide reactivity profile normalization, I required an untreated read depth
of 5000.
4.3.4 Standard error filter
For individual nucleotides, I imposed a filter based on the standard error of the SHAPE
reactivity signal, requiring that:
stderr ≤ |SHAPE| ∗0.5+0.4 (2)
At unreactive positions, this filter requires that the standard error be no greater than the
reactivity at which the SHAPE pseudo-free energy term in RNAstructure8 is zero. At
highly reactive positions, this filter allows comparatively larger standard errors, while still
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rejecting highly noisy positions.
4.4 Validation and global trends
4.4.1 Coverage and structure modeling statistics
HiSeq 2x100 rapid run
Sample Paired-end reads Reads mapping to E. coli
SHAPE treated 75,579,880 73,698,260
Untreated 62,957,520 61,536,398
Denatured 61,953,160 60,747,140
Table 4.1: Sequencing statistics.
A single lane of a HiSeq sequencing run produced nearly 2 billion reads mapping
to the E. coli genome (Table 4.1). 1.89 million, or 41% of nucleotides in the E. coli
genome passed the data quality filter given in equation (2). However, these nucleotides
are not continuously distributed. Only 940 thousand, or 20% of genomic nucleotides
are located in transcripts with median untreated sequencing depths above 1000, for a
total of 562 transcripts. Only 260 thousand, or 6% of genomic nucleotides pass a more
stringent median depth requirement of 5000, in a total of 166 transcripts. Given that the
majority of nucleotides in the E. coli genome appear to be transcribed, the present study
provides accurate structural information for a subset of the transcriptome. A plot of genome
coverage makes this apparent (Figure 4.2).
Accurate structural information is available for a number of transcripts, primarily
highly expressed “housekeeping” RNAs9 (Figure 4.3), from short ncRNAs of about 200
nucleotides to long mRNAs of up to 15,000 nucleotides. In contrast to other massively
parallel sequencing approaches for RNA structure, SHAPE-MaP reports single-nucleotide
resolution reactivity information including all four nucleotide types (Figure 4.4). SHAPE
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Figure 4.2: E. coli genome coverage. Outer track: depth of sequencing coverage in the
untreated control sample, shown as both a max and median over 1000-nucleotide windows.
A nominal threshold for the sequencing depth required to obtain high-quality SHAPE
reactivity profiles and structure models is shown in green. Gaps in coverage (for example,
at 0.3 Mb) reflect prophage deletions in the DH5α strain probed compared to the K12
reference strain. Middle track: “SHAPE data quality” is the count of nucleotides passing
a filter based on the standard error of the SHAPE reactivity signal (see equation (2)) over
1000-nucleotide windows, and complements the data quality assessment based on depth
alone. Inner track: Transcripts with untreated sample median depths above 5000, colored
by transcript length.
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reactivities closely matched known patterns of base pairing for three highly-structured
ncRNAs (Figure 4.5). SHAPE-constrained models created using RNAstructure and
ShapeKnots10 recovered 93% and 85% of base pairs for the 6S rRNA and the RNA
component of RNase P, respectively (Table 4.2). The unusually highly pseudoknotted
structure of tmRNA precludes its accurate prediction using current methods.
Name Length Pseudoknots Sensitivity (%) PPV (%)
6S ncRNA 183 0 93.0 91.4
RNase P 377 2 85.5 86.9
Table 4.2: Structure modeling statistics for two previously characterized RNA
structures.
Highly-structured RNAs are easily discoverable by identifying transcripts with long
regions of low median reactivity (as described in section 4.5.1, “Low-SHAPE regions”).
Unlike previous approaches, SHAPE-MaP allows the modeling of novel structures. An
intriguing example is the mRNA encoding major membrane lipoprotein (lpp) (Figure 4.6).
SHAPE reactivities clearly indicate the lpp transcript is highly base paired, but this structure
has been uncharacterized until now, with the exception of a transcription terminator hairpin
containing 13 base pairs11. The lpp mRNA is highly abundant, largely poly-adenylated,
and relatively long-lived, with a half-life of 12 minutes in cells12. The translation start
site is positioned in a large single-stranded loop, the translation stop codon is located in a
smaller loop, and no pseudoknots are predicted. The function of the lpp RNA structure is
unknown, but it could act to resist exonuclease degradation or to aid recognition by protein
factors involved in poly(A) polymerization, such as Hfq11.
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Figure 4.4: Representative SHAPE-MaP reactivity profiles. Reactivity profiles for three
highly expressed ncRNAs. Error bars indicate standard errors.
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Figure 4.5: Representative secondary structures. SHAPE-MaP reactivity colorings
superimposed on accepted secondary structures for three RNAs.
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Figure 4.6: Proposed secondary structure for the transcript encoding major
membrane lipoprotein. Possible poly-adenylation of this mRNA is not shown, as the
current randomly-primed data do not provide information about the very ends of transcripts.
A previously reported terminator hairpin11 is not included in this model—its addition
would likely change the base pairing pattern of 8 nucleotides on the 5′ end of the RNA.
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4.4.2 Large-scale trends in E. coli transcript flexibility
Several previous reports of transcriptome-scale RNA structure probing using
massively parallel sequencing have included average reactivity or cleavage profiles over
the regions surrounding start codons, over the regions surrounding stop codons, and
over coding region interiors for several eukaryotic organisms1–4. A similar analysis was
performed over the bacterial transcripts in the current study (Figure 4.7, panel A). The
large standard deviations emphasize the wide variation in local transcript flexibility, and
suggest that there are no universal RNA structure features in relation to translation start
and stop sites.
However, several trends are apparent. The 50 nucleotides surrounding start codons
exhibit a distinctive pattern of reactivity (Figure 4.7, panel C). This trend is present in start
codons both near the 5′ ends of transcripts and 3′ of intergenic regions (Figure 4.7, panel
A). Stop codons display a simple increased reactivity, regardless of whether they precede
intergenic regions or 3′ UTRs.
If the trend for increased stop codon flexibility reflected a functional RNA structural
feature, out-of-frame stop codons could be expected to show a different range of reactivities
than in-frame codons, reflecting the effects of selection. A comparison of in-frame and out-
of-frame stop codons (Figure 4.7, panel D) shows no evidence for selection of stop codon
flexibility, suggesting that the average reactivity trends are largely a result of local sequence
content. Since base pairs containing adenosine and uridine usually participate in one less
hydrogen bond than base pairs containing guanosine and cytidine, sequences in an RNA
with high AU content will on average display greater flexibility than regions with high GC
content13. Indeed, the three-nucleotide centered mean AU content closely follows the mean
SHAPE reactivity (Figure 4.8, panels B and C), with a linear correlation R value of 0.67.
In contrast, the single-nucleotide AU content correlates more poorly with mean SHAPE
reactivity, especially over coding regions. In coding regions, a periodic sequence trend is
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clearly present, but it does not bias the reactivity profile (Figure 4.8, panel A). This analysis
provides a strong demonstration that SHAPE-MaP accurately reports nucleotide flexibility
with little nucleobase bias. Previous reports of a periodic flexibility or base pairing trend
within coding regions1–4 are likely showing a side effect of using probes or enzymes that
only report on a subset of the four nucleotides.
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Figure 4.7: SHAPE reactivities across untranslated, protein-coding, and intergenic
regions. (A) Mean and standard deviation of SHAPE reactivities surrounding various
genome features. Short vertical black lines below the top panel indicate aligned locations.
(B) Number of high-quality data points (transcripts) at each position. Noisy locations in
the mean reactivity profile generally fall in regions with low representation, for example,
in the intergenic regions, to which less than 100 transcripts contribute. (C) Close-up of the
trend surrounding start codons. Start codons tend to be highly reactive, as are nucleotides
centered around 18 nt upstream. The nucleotide immediately downstream of start codons
tends to be lowly reactive. A general (D) Comparison of the three major stop codons, both
in-frame and out-of-frame. Bars show mean SHAPE reactivity, and lines show standard
deviation. No significant differences between in-frame and out-of-frame codons exist,
providing no evidence for selection for or against stop codon flexibility.
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4.5 Transcriptome-wide RNA structure motif discovery by local sequence and MaP
clustering
The high levels of variability in SHAPE reactivities across genomic features (see
Figure 4.7) suggested that pairwise alignment of local transcriptome regions and clustering
using similarity scores could detect conserved or duplicated RNA structures where
alignment to genomic features failed. Regions with relatively low SHAPE reactivities are
good candidates for highly structured RNAs.
4.5.1 Computational methods
Low-SHAPE regions
Low-SHAPE regions were selected as follows. The standard error filter described in
Section 4.3.4 was applied to each nucleotide, excluding noisy positions. A windowed 50-
nucleotide centered median SHAPE reactivity was calculated for each transcript, excluding
50-nt regions with more than 25 nucleotides thrown out in the previous step. Nucleotides
with windowed medians less than or equal to 0.25 (a low reactivity) were collected into
contiguous regions. These regions were expanded by 25 nucleotides on both ends, and
overlapping regions merged. The resulting regions were segmented into 150-nucleotide
windows, with a step size interval of 50 nucleotides. Windows with more than 25 excluded
nucleotides were not included.
Sequence alignment
Pairwise sequence alignments were performed using an approach developed by Andy
Lavender and others in the Weeks lab (submitted). Briefly, the Needleman-Wunsch
dynamic programming method for finding the optimal global sequence alignment was
performed, with the addition of an optional SHAPE reactivity match score. Standard
alignment parameters were as follows: gap open penalty: -8.5, gap extension penalty:
0, sequence match bonus: 2, sequence mismatch penalty: -0.5. The optional SHAPE
reactivity score was given for each pair of nucleotides in the scoring matrix by:
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SHAPEscore = b+n0 ∗ e−l∗|SHAPEA−SHAPEB| (3)
with n0=4, b=-1, and l=1. For speed, the alignment algorithm was re-implemented in the C
programming language (from its original implementation in python). For the alignment and
clustering shown in Figure 4.9, alignments were performed with sequence alone, without
the optional SHAPE match score.
Distance matrix processing
A distance matrix was calculated, recording the alignment scores for all possible
pairs of 150-nucleotide low-SHAPE regions. Scores were discarded for which less than
30 nucleotides overlapped in the alignment. Scores were normalized to the maximum
alignment score.
Because sliding windows contain regions of identical sequence, a given region may
align to contiguous windows with similar scores, confounding visualization. For each 150-
nucleotide low-SHAPE region, alignment scores to contiguous low-SHAPE regions were
therefore pruned by iteratively selecting the highest score and removing the scores with
indices within +2 and -2 of the maximum scoring region. After this process, scores in the
top 99.9th percentile were retained for clustering.
Clustering
Clustering was performed using the Markov Cluster Algorithm14, using default
parameters and the distance matrix described above.
4.5.2 Results
676 low-SHAPE regions of 150 nucleotides each, with a step size of 50 nucleotides,
were extracted from the overall dataset for this analysis, as detailed in Section 4.5.1.
Attempts to identify conserved RNA structures without respect to sequence (clustering
using pairwise SHAPE profile correlations) were inconclusive, but should be revisited
with access to a more exhaustive dataset. This section will instead focus on a simpler
approach—the identification of RNA structures repeated in the transcriptome by clustering
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using sequence alignment scores between low-SHAPE regions.
A schematic of the results of this analysis is shown in Figure 4.9. The detection
of pre-tRNAs provides a validation of this approach, since tRNAs are highly-structured
RNAs with a high degree of sequence conservation15. The other RNA structure elements
identified by this approach are repetitive extragenic palindromic (REP) elements and
transcriptional terminators (in some cases previously unannotated).
REP elements are mobile genomic elements in bacteria composed of short inverted
complementary regions of about 10–30 nucleotides separated by a spacer of about 2–6
non-conserved nucleotides16. REP elements are often located near each other in tandem
groups of 2 to 4, and usually fall in intergenic (non-coding) regions17. Currently, the best-
supported model explaining the distribution of these elements describes REPs as selfish
DNA replicators within the genome18, in some cases using specific transposases to catalyze
replication19,20. If this is the case, the folded RNA structure formed by these elements is
likely to be a side effect of the sequences necessary for their propagation, and not a cause,
although there are limited examples of REP hairpins that modulate RNA transcription or
degradation21. Even so, these elements provide another clear demonstration of the accuracy
of SHAPE-MaP data, since highly reactive nucleotides in these elements occur precisely at
the non-conserved spacers between inverted repeats (Figure 4.10).
Transcriptional terminators are RNA hairpins that serve to terminate transcription
without the requirement for external protein factor binding (commonly termed “intrinsic
termination”). These elements have typically been described as short hairpins, containing
13–23 total nucleotides22, although extended structures have been described that appear
to enhance transcription termination23. The current analysis identified transcriptional
terminators likely to fold into longer extended hairpins, which surprisingly contained up
to 127 nucleotides (Figures 4.11 and 4.12).
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Poor alignments
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Transcript
Contiguous region
150 nt window
(50 nt step)
Low-SHAPE regions
Figure 4.9: Sequence clusters. Known conserved, repeated sequences are clustered,
including pre-tRNAs, transcription terminators, and repetitive extragenic palindromic
(REP) elements. Arcs between regions indicate pairwise alignment scores above the
threshold described in Section 4.5.1. Arcs between regions in the same cluster use the
same color. Clusters with less than three member regions were excluded from this plot.
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Figure 4.11: Selected terminators. (A) Sequence alignment of two 150-nucleotide
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4.6 Future improvements
As a pilot study, this dataset points to the need for increased data quality, either
by increasing the total read depth, by increasing the signal above background, or by
leveling the distribution of cDNAs in the sequencing library. Increasing the sequencing
depth is the simplest approach to improve data quality, but is currently prohibitively
expensive24,25. This approach is also likely to provide diminishing returns, since additional
sequencing improves the coverage of highly-abundant transcripts to a greater degree than
rare transcripts.
Increased signal above background could be obtained in at least four ways: increased
SHAPE adduct formation, increased adduct detection rate, decreased background signal,
and revised sequencer sample loading ratios. Increased adduct formation would require
either multiple rounds of modification or the creation of newer, more highly soluble SHAPE
reagents. Increased adduct detection rates could in theory be obtained by engineering
improved reverse transcriptases or by changing reverse transcription conditions, although
the current adduct detection rate is already estimated at 50%. Decreased background signal
could also be obtained by reverse transcriptase engineering26–28. The contributions of the
three samples (SHAPE-modified, untreated, and denatured) to the standard error of the
SHAPE reactivity signal (ch. 3 equation 3) suggest that decreased noise for the same total
sequencing depth could be obtained by reducing the concentration of untreated sample
cDNA loaded on the sequencer relative to the other samples.
Leveling the abundance distribution of cDNAs in the library to be sequenced would
improve signal quality for rare transcripts. This could be performed using a method
called cDNA normalization29, in which double-stranded cDNA is denatured, renatured,
and treated with a double-stranded DNA nuclease. This process selectively digests highly
abundant cDNAs, since DNAs with rare sequences are more likely to be unpaired at the
time of DNase treatment30.
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4.7 Conclusion
This is the first study applying SHAPE-MaP to a bacterial transcriptome. SHAPE-
MaP accurately reported nucleotide-resolution structural information in this large-scale
experiment. For well-studied RNAs, SHAPE-MaP data agreed closely with known
structures, while for poorly characterized RNAs, these data enabled the accurate modeling
of novel structures. Profiling SHAPE reactivity over short windows identified regions
of high structure, and clustering these structured regions by sequence alignment score
identified repeated structured elements in the E. coli genome, including pre-tRNAs,
transcription terminators, and REP elements. With improvements in experimental
efficiency, SHAPE-MaP will allow the comprehensive structural characterization of nearly
all the RNAs produced in a bacterium.
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